SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

计划入组 150 人 · 首次发布于 2026 年 3 月 4 日

Hepatocellular Carcinoma Treated With Iodine-125 Implantation

计划入组 136 人 · 首次发布于 2012 年 10 月 30 日

CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors

计划入组 38 人 · 首次发布于 2024 年 1 月 8 日

Iodine 125I Brachytherapy Source

Iodine-125 BAN 2401 (BioArctic)

Iodine[I-125]

MANHATTAN PSYCHIATRIC CENTER

United States

HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH

United States

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Cellectar Biosciences Submits Phase 1b Protocol for CLR 125 Radiopharmaceutical in Triple-Negative Breast Cancer

Cellectar Partners with Evestia Clinical for Phase 1b Trial of CLR 125 Radiopharmaceutical in Triple-Negative Breast Cancer

Cellectar Biosciences Raises $2.5 Million Through Warrant Exercise to Advance Cancer Drug Development